Combination of concurrent targeted and immune-therapy with nivolumab and cetuximab: new perspectives for squamous cell carcinoma treatment
Head and Neck Tumors (HNT)
,
Volume 10; doi:10.17650/2222-1468-2020-10-3-111-117
The publisher has not yet granted permission to display this abstract.
Click here to see the statistics on "Head and Neck Tumors (HNT)" .